VISTAGEN THERAPEUTICS, INC. Fair Value Assumptions, Risk Free Interest Rate (Deprecated 2018-01-31)
VISTAGEN THERAPEUTICS, INC. (VTGN) reported Fair Value Assumptions, Risk Free Interest Rate (Deprecated 2018-01-31) of 1.99% for the 6-month period ending 2017-09-30, per its 10-Q filed 2018-02-12.
Discontinued › Notes › Fair Value Measures and Disclosures
us-gaap:FairValueAssumptionsRiskFreeInterestRate · last filed 2018-02-12
- VISTAGEN THERAPEUTICS, INC. fair value assumptions, risk free interest rate (deprecated 2018-01-31) for the quarter ending 2016-06-30 was 1.27%.
| Period end | Fair Value Assumptions, Risk Free Interest Rate (Deprecated 2018-01-31) 3 month | Fair Value Assumptions, Risk Free Interest Rate (Deprecated 2018-01-31) 6 month | Fair Value Assumptions, Risk Free Interest Rate (Deprecated 2018-01-31) 6 month as first filed | Fair Value Assumptions, Risk Free Interest Rate (Deprecated 2018-01-31) 9 month |
|---|---|---|---|---|
| 2017-09-30 | 1.99% 10-Q · filed 2018-02-12 | |||
| 2016-12-31 | 1.27% 10-Q · filed 2017-02-13 | |||
| 2016-09-30 | 1.29% 10-Q · filed 2018-02-12 | 1.27% 10-Q · filed 2016-11-14 | ||
| 2016-06-30 | 1.27% 10-Q · filed 2016-08-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| MUSTANG BIO, INC. (MBIO) | United States | $0.013B | |
| AEON Biopharma, Inc. (AEON) | United States | $0.013B | -0.36 |
| LISATA THERAPEUTICS, INC. (LSTA) | United States | $0.014B | -2.13 |
| Tempest Therapeutics, Inc. (TPST) | United States | $0.013B | |
| Aspire Biopharma Holdings, Inc. (ASBP) | United States | $0.012B | -0.60 |
| BIOVIE INC. (BIVI) | United States | $0.012B | |
| BullFrog AI Holdings, Inc. (BFRG) | United States | $0.014B | |
| ADIAL PHARMACEUTICALS, INC. (ADIL) | United States | $0.012B | |
| Vyome Holdings, Inc (HIND) | United States | $0.014B | -1.38 |
| Tvardi Therapeutics, Inc. (TVRD) | United States | $0.014B |